Unknown

Dataset Information

0

A rational approach to COVID-19.

ABSTRACT: It is crucial to use the wealth of information emerging from the ongoing SARS-CoV-2 pandemic and confront COVID-19 with a rational approach. There are proactive steps to prevent and fight COVID-19. Management of the disease should be according to clinical features and laboratory test markers and personalized therapeutic targets.

SUBMITTER: Mehrian-Shai R 

PROVIDER: S-EPMC7753102 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

A rational approach to COVID-19.

Mehrian-Shai Ruty R  

Human genomics 20201222 1

It is crucial to use the wealth of information emerging from the ongoing SARS-CoV-2 pandemic and confront COVID-19 with a rational approach. There are proactive steps to prevent and fight COVID-19. Management of the disease should be according to clinical features and laboratory test markers and personalized therapeutic targets. ...[more]

Similar Datasets

Unknown Cohort survey of healthcare workers with COVID-19 infection
| S-BSST563 | biostudies-other
Unknown Rational design of potent anti-COVID-19 main protease drugs: An extensive multi-spectrum in silico approach.
| S-EPMC7879066 | biostudies-literature
Genomics Covid-19
| PRJEB42396 | ENA
Unknown Phototherapy as a Rational Antioxidant Treatment Modality in COVID-19 Management; New Concept and Strategic Approach: Critical Review.
| S-EPMC7555229 | biostudies-literature
Unknown Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation.
| S-EPMC7572583 | biostudies-literature
Unknown Proteomic blood profiling in mild, severe and critical COVID-19 patients
| S-BSST416 | biostudies-other
Unknown Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach.
| S-EPMC7912585 | biostudies-literature
Unknown Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets.
| S-EPMC8206563 | biostudies-literature
Unknown Decreased memory B cells frequencies in COVID-19 Delta variant vaccine breakthrough infection
| S-SCDT-EMM-2021-15227 | biostudies-other
Unknown Monocytopenia, morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes
| S-SCDT-EMM-2020-13038 | biostudies-other